Sign In

Mitchell Efros

CEO Verified Clinical Trials / Asst Professor Urology Preventing professional research subjects in clinical trials Decentralized clinical trials solution / Reduce placebo rates in clinical trials / Drug development

Professional Background

Mitchell Efros is an esteemed leader in the clinical research field, serving as the President and Chief Executive Officer of Verified Clinical Trials™ (VCT). Under his visionary leadership, VCT has established itself as the world's largest and most comprehensive global research subject database registry, which is crucial for enhancing the quality and safety of research participants in clinical trials. Hailing from a distinguished medical background, Efros brings vast expertise to the realm of clinical trials, helping to steer both biotech companies and major pharmaceutical firms towards achieving their research objectives successfully. His innovative approaches not only promote research subject safety but also significantly reduce placebo rates, contributing greatly to the integrity of clinical research overall.

VCT’s impact is felt globally, utilized across numerous phase 1 clinical trial sites and in more than 40 countries for phase 2 and phase 3 clinical trials. The platform’s efficiency and effectiveness in streamlining the verification of clinical trial subjects enhance the reliability of the data collected, serving as an excellent return on investment for all stakeholders in clinical research. With VCT at the forefront, Efros is instrumental in minimizing the risk of clinical trial failures, thereby accelerating the pathway to bringing safe and effective drugs to market.

Education and Achievements

Mitchell Efros has a solid academic foundation that has equipped him with the essential skills and knowledge to excel in the medical and clinical research fields. He completed his Bachelor of Science in Biology at Syracuse University, where he developed a keen understanding of biological sciences, which he later applied in the medical field. Following this, Efros pursued his Doctor of Medicine degree at New York Medical College, where he honed his clinical and scientific expertise, setting the stage for a successful medical career.

Before leading VCT, Dr. Efros served as an Assistant Professor of Urology at Stony Brook University Hospital, part of Stony Brook Medicine. In this academic position, he contributed to the education and training of future medical professionals, sharing his wealth of knowledge and expertise in urology. His commitment to education and mentorship underscores his dedication to advancing the medical field.

Moreover, as the former President and Medical Director at Accumed Research Associates, he garnered valuable experience managing clinical research and overseeing medical practices, further enhancing his credentials as a leader within the clinical research ecosystem.

Achievements

Mitchell Efros' career reflects a series of significant achievements that underscore his influence and commitment to improving clinical trial methodologies. His role in establishing VCT not only showcases his entrepreneurial spirit but also invites a paradigm shift in how clinical trials assess and validate research subjects. Efros’ leadership has been pivotal in ensuring that VCT operates as an indispensable resource, enhancing the safety of research subjects and the quality of clinical data. This has resulted in substantial time and cost savings for the stakeholders involved in clinical trials, such as research sponsors and regulatory bodies.

Through his efforts, Efros has contributed to a transformative approach within the clinical research community, focusing not just on the end products but also on the processes that lead to successful, data-driven results. His ongoing initiatives strive towards excellence in the industry, emphasizing the importance of high-quality subject recruitment and rigorous trial standards. As a result of his contributions, clinical trials can proceed with enhanced confidence, ultimately supporting the delivery of groundbreaking therapies and improved patient outcomes.

Related Questions

How did Mitchell Efros develop his expertise in clinical research and subject safety?
What inspired Mitchell Efros to establish Verified Clinical Trials as a leader in the industry?
In what ways does Mitchell Efros envision the future of clinical trials evolving?
How has Mitchell Efros's education influenced his approach to leadership in clinical research?
What are some notable successes achieved under Mitchell Efros's guidance at Verified Clinical Trials?
Mitchell Efros
Add to my network

Location

Garden City, New York, United States